Murine dendritic cells modified with CXCL10 gene and tumour cell lysate mediate potent antitumour immune responses in mice.

about

Chemokines as Cancer Vaccine Adjuvants.Applications of chemokines as adjuvants for vaccine immunotherapy.

P2860

Q33792344-090F581D-E869-4A6A-86E3-1677A6E33744 Q47288431-5DA2FBC7-DA09-4A99-8AC3-F7B64623F125

P2860

Murine dendritic cells modified with CXCL10 gene and tumour cell lysate mediate potent antitumour immune responses in mice.

Item

http://www.wikidata.org/entity/Q40185066

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Murine dendritic cells modifie ...... mour immune responses in mice.

@en

type

Item

label

Murine dendritic cells modifie ...... mour immune responses in mice.

@en

prefLabel

Murine dendritic cells modifie ...... mour immune responses in mice.

@en

P1476

Murine dendritic cells modifie ...... mour immune responses in mice.

@en

P2093

Li B

http://www.w3.org/2001/XMLSchema#string

Li Q

http://www.w3.org/2001/XMLSchema#string

Wei XB

http://www.w3.org/2001/XMLSchema#string

Wu CQ

http://www.w3.org/2001/XMLSchema#string

Zhang XH

http://www.w3.org/2001/XMLSchema#string

Zhao QL

http://www.w3.org/2001/XMLSchema#string

Zhong CP

http://www.w3.org/2001/XMLSchema#string

P2860

Dendritic cells in cancer immunotherapy.

Active immunization against cancer with dendritic cells: the near future.

Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo.

The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3

Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo

IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo.

Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease.

Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help.

Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors.

Intratumoral coinjection of two adenoviral vectors expressing functional interleukin-18 and inducible protein-10, respectively, synergizes to facilitate regression of established tumors.

P304

8-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-3083.2006.01861.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6588185

http://www.w3.org/2001/XMLSchema#string

P698

17212761

http://www.w3.org/2001/XMLSchema#string

Murine dendritic cells modified with CXCL10 gene and tumour cell lysate mediate potent antitumour immune responses in mice.

about

P2860

P2860

Murine dendritic cells modified with CXCL10 gene and tumour cell lysate mediate potent antitumour immune responses in mice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698